PIN24 COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB AMONG PRETERM INFANTS COVERED BY MEDICAID IN THE UNITED STATES
Keyword(s):
2017 ◽
Vol 216
(3)
◽
pp. 345-355
◽
Keyword(s):
Keyword(s):
2020 ◽
1996 ◽
Vol 3
(4)
◽
pp. 477-479
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 6
(4)
◽
pp. 477-486
◽
Keyword(s):
2014 ◽
Vol 33
(6)
◽
pp. e135-e140
◽
Keyword(s):